Predictive Oncology Inc. (AGPU)

Market Cap	20.16M
Revenue (ttm)	1.66M
Net Income (ttm)	-84.33M
Shares Out	3.39M
EPS (ttm)	-149.54
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,123
Open	6.06
Previous Close	n/a
Day's Range	5.45 - 6.06
52-Week Range	3.88 - 45.90
Beta	1.35
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 27, 2026

About AGPU

Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in drug development. Its Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid wa...

• Founded: 2002
• Employees: 24
• Stock Exchange: NASDAQ
• Ticker Symbol: AGPU
• Website: https://predictive-oncology.com

Financial Performance

In 2024, Predictive Oncology's revenue was $1.62 million, a decrease of -0.24% compared to the previous year's $1.63 million. Losses were -$12.66 million, -9.44% less than in 2023.